跳至主要内容
临床试验/DRKS00017371
DRKS00017371尚未招募不适用

Characteristics related to Assessments of disease, patient and treatment associated with long-term survival in ovarian cancer patients (CAROLIN)-Intergroup study NOGGO/ A-AGO - NOGGO ov45

ord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie - NOGGO e.V.0 个研究点目标入组 300 人开始时间: 2019年5月22日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
Female

入选标准

  • Female, age at least 18 years
  • Participant must be able to understand the study procedures and agree to participate in the study by providing written informed consent
  • For the last chemotherapy course prior to inclusion in the NIS the patient must have achieved a partial (PR) or complete (CR) tumor response
  • Patients eligible for Niraparib maintenance therapy according to SmPC and histologically diagnosed relapsed OC, fallopian tube cancer, or primary peritoneal cancer
  • Patients can be included after therapy decision of Niraparib treatment (decision to start Niraparib therapy must have been taken independently) and for up to 3 months after start of Niraparib therapy
  • Patient is able to take oral medications

排除标准

  • Known hypersensitivity to the components of the product
  • Pregnant or breast-feeding patients

研究者

发起方
ord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie - NOGGO e.V.

相似试验